Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

111In-benzyl-DTPA-ZHER2:342

Known as: (111)In-Benzyl-DTPA-Z(HER2:342) 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Background: Human epidermal growth factor receptor type 2 (HER2) is abundant in a wide variety of tumors and associated with the… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Highly Cited
2009
Highly Cited
2009
In vivo imaging of human epidermal growth factor receptor type 2 (HER2) expression may allow direct assessment of HER2 status in… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
2009
2009
PurposeAffibody molecules are a novel class of tumour-targeting proteins, which combine small size (7 kDa) and picomolar… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • table 3
Highly Cited
2008
Highly Cited
2008
PurposeAffibody molecules are low molecular weight proteins (7 kDa), which can be selected to bind to tumour-associated target… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • table 3
Highly Cited
2007
Highly Cited
2007
Detection of HER2-overexpression in tumors and metastases is important for the selection of patients who will benefit from… Expand
2007
2007
Affibody molecules present a new class of affinity proteins, which utilizes a scaffold based on a 58-amino acid domain derived… Expand
2007
2007
AIM Radionuclide imaging of the HER2 receptor, which is a target for trastuzumab therapy, can provide important diagnostic… Expand
2007
2007
The use of radionuclide molecular imaging enables the selection of patients for treatment using molecular medicine. Preclinical… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table I